Pingping Zhang (she/her/hers)

Cellentia, Inc.

Poster(s):

• (W1430-02-08) In Vitro Method Using Circulating Tumor Cells-Derived Organoids from Patients with Solid Tumors to Transform Oncology Drug Development
  Wednesday, May 15, 2024

  2:30 PM – 3:30 PM PT

• (T1330-02-10) Novel Immunoassay Technology: Evaluating the PIXI Platform for Rapid Quantitation with Automation, Wide Dynamic Range, and Small Sample Volume Requirement
  Tuesday, May 14, 2024

  1:30 PM – 2:30 PM PT